CPT code 43255 represents a flexible transoral esophagogastroduodenoscopy (EGD) specifically performed to achieve hemostasis and control bleeding within the upper gastrointestinal tract using any method. The upper gastrointestinal tract includes the esophagus, stomach, and either the duodenal bulb or the second portion of the duodenum. Upper gastrointestinal bleeding is a common and potentially life-threatening emergency that requires prompt endoscopic evaluation and intervention. During this procedure, the physician utilizes a flexible video endoscope, passing it through the patient's mouth and oropharynx down into the esophagus and further into the gastric and duodenal cavities. Upon identifying the source of hemorrhage—which may manifest as an actively bleeding peptic ulcer, a Mallory-Weiss tear at the gastroesophageal junction, bleeding angiodysplasia, a Dieulafoy lesion, or erosive hemorrhagic gastritis—the physician intervenes using one or a combination of hemostatic techniques. These techniques can include thermal coagulation (such as bipolar electrocoagulation, heater probe, or argon plasma coagulation), mechanical therapy (such as the application of endoscopic clips or band ligation, though variceal ligation has a specific code), or injection therapy (such as the submucosal injection of epinephrine or sclerosants to induce vasoconstriction and local tamponade). The chosen method depends on the nature, location, and severity of the bleeding lesion. Endoscopic control of bleeding is critical for stabilizing the patient, reducing the need for blood transfusions, avoiding more invasive surgical interventions, and decreasing mortality. It is important to note that the control of bleeding must be the primary intent or a significant therapeutic addition for a naturally occurring bleed. If a physician causes bleeding during another endoscopic intervention, such as a mucosal biopsy or snare polypectomy, the control of that iatrogenic bleeding is generally considered an integral part of the primary procedure and is not separately reportable with 43255 unless it occurs at a separate anatomical site or during a distinctly separate patient encounter. Post-procedural care typically involves monitoring the patient for re-bleeding, managing their hemodynamic status, and initiating appropriate pharmacological therapies like high-dose proton pump inhibitors.